I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Hamid Rabb, M.D.
Medical Director of the Johns Hopkins Kidney Transplant Program
Professor of Medicine
Languages: English, Bengali, French, Spanish
Expertise: Acute Kidney Injury (AKI), Internal Medicine, Kidney Transplant, Nephrology
Research Interests: Biomarker discovery; Organ cross talk; Lymphocytes; Kidney ischemic injury
Request an Appointment
I live in Maryland
Request an appointment through My
I live outside of Maryland
I live outside of the United States
Dr. Rabb attended medical school at McGill University in Montreal and graduated as University Scholar. After internship and residency in Internal Medicine at the UCLA School of Medicine, Harbor-UCLA Medical Center, he completed a clinical nephrology fellowship at the Massachusetts General Hospital and Harvard Medical School. This was followed in the same institutions by basic research training in leukocyte biology/immunology. Dr. Rabb is currently Professor in the Department of Medicine, and Medical Director of the Johns Hopkins Kidney Transplant Program. He is a member of the American Society of Clinical Investigation, American Association of Professors, a permanent member on NIH study section, and past Chair of Scientific Studies for the American Society of Transplantation.
- Medical Director of the Johns Hopkins Kidney Transplant Program
- Professor of Medicine
- Professor of Surgery
Departments / Divisions
Centers & Institutes
- MD, McGill University School of Medicine (1985)
- UCLA Harbor Medical Center / Internal Medicine (1988)
- Massachusetts General Hospital / Nephrology (1991)
- American Board of Internal Medicine / Internal Medicine (1988)
Research & Publications
- Rabb H, Sharma CP, Michishita M, Brown D, Arnaout MA. Regulation of complement receptor type 3 (CD11b/CD18): function and internalization by the cytoplasmic tail of its ß-subunit (CD18). J Immunology 150:4019-4030, 1993
- Rabb H, Mendiola CC, Dietz J, Saba SR, Issekutz TB, Abanilla F, Bonventre J, Ramirez G. Role of CD11a & CD11b in ischemic acute renal failure in rats. Am J Physiol Renal 267:F1052-1058, 1994
- Rabb H, Martin JG. An emerging paradigm shift on the role of leukocyte adhesion molecules in inflammation. J Clin Invest 100:2937-8,1999
- Kramer A, Postler G, Salhab K, Mendez C, Carey L, Rabb H. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 55:2362-7, 1999
- Rabb H, Daniels F, O’Donnel M, Haq M, Saba S, Keane W, Tang W. Pathophysiologic role of T cells in renal ischemia reperfusion injury in mice. Am J Physiol Renal 279:F525-531, 2000
- Nemoto T, Yokota N, Keane W, Rabb H. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int 59:246-251, 2001
- Burne M, Daniels F, Elgandour A, Muyeddi S, Colvin R, O’Donnell M, Rabb H. Identification of the CD4+ T cell as a major modulator of renal ischemia reperfusion injury. J Clin Invest 108:1283-90, 2001
- Burne-Taney M, Ascon D, Yokota N, Racusen L, Baldwin W, Rabb H. B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol 171:3210-5, 2003
- Craem J, Brady H, Rabb H. Cell-matrix and cell-cell interactions in the kidney. Ed. Brenner BM: Brenner & Rector’s The Kidney, Saunders. 2004
- Rabb H. Paracrine and differentiation mechanism underlying stem cell therapy for the damaged kidney. Am J Physiol Renal 289:F29-30, 2003
Activities & Honors
- American Association of Professors
- American Society of Clinical Investigation
- NIH study section
- Past Chair, Scientific Studies for the American Society of Transplantation